Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 237-246

  Chazaud, Bénédicte ^a   Ricoux, Rémy ^a   Christov, Christo ^a   Plonquet, Anne ^a   Gherardi, Romain K ^a   Barlovatz Meimon, Georgia ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0036142749     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64367-2     Document Type: Article

References (57)

1. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
2. Extracellular matrix remodeling by metalloproteinases and plasminogen activators
3. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin
4. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis
5. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes
6. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes
7. Very low density lipoprotein receptors binds and mediates endocytosis of urokinasetype plasminogen activator-type-1 plasminogen activator inhibitor complex
8. Purified a2-macroglobulin receptor/LDL receptor-related protein binds urokinase:plasminogen activator inhibitor type-1 complex
9. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
10. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
11. Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptorrelated protein
12. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
13. The urokinase-type plasminogen activator system in cancer metastasis: A review
14. Plasminogen activator inhibitor-type 1 in cancer: Therapeutic and prognostic implications
15. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
16. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues
17. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
18. 3 binding to vitronectin
19. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system
20. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
21. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading
22. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility
23. Urokinase receptor mediates mechanical force transfer across the cell surface
24. Cell migration: A physically integrated molecular process
25. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro
26. Breast tumor cell lines from pleural effusions
27. 2-macroglobulin receptor in human breast carcinomas
28. Consensus conference on the classification of ductal carcinoma in situ
29. Substrates for astrocytoma invasion
30. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity
31. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780
32. Characterization of morphogenetic and invasive abilities of human mammary epithelial cells: Correlation with variations of urokinase-type plasminogen activator activity and type-1 plasminogen activator inhibitor level
33. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix
34. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness
35. Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines
36. Autocrine saturation of pro-urokinase receptors on human A431 cells
37. Regulation of integrin function by the urokinase receptor
38. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
39. Regulation of urokinase receptor transcription by ras- and rho-family GTPases
40. Srcdependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
41. Leukocyte polarization in cell migration and immune interactions
42. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis
43. The urokinase receptor is required for human monocyte chemotaxis in vitro
44. Urokinase: A chemotactic factor for polymorphonuclear leukocytes in vivo
45. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
46. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain
47. Cytoskeletal rearrangement during migration, and activation of T lymphocytes
48. Stromal cell-derived factor-la associates with heparan sulfates through the first βstrand of the chemokine
49. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans
50. Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis
51. Integrating conflicting chemotactic signals: The role of memory in leukocyte navigation
52. Real-time analysis of integrin-mediated chemotactic migration of T lymphocytes within 3-D extracellular matrix-like gels
53. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization
54. Receptor-mediated endocytosis of CC-chemokines
55. Chemokine-induced signal transduction in leukocytes
56. Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein